Lisinopril/hydrochlorothiazide: Difference between revisions
Appearance
Content deleted Content added
Anypodetos (talk | contribs) |
Updating {{drugbox}} (no changed fields - added verified revid - updated 'ChemSpiderID_Ref', 'DrugBank_Ref', 'UNII_Ref', 'ChEMBL_Ref', 'ChEBI_Ref', 'KEGG_Ref', 'StdInChI_Ref', 'StdInChIKey_Ref', 'DrugBank_Ref', 'ChEBI_Ref') per [[WP:CHEMVALID|Chem/Dr |
||
Line 1: | Line 1: | ||
{{Drugbox |
{{Drugbox |
||
| verifiedrevid = |
| verifiedrevid = 447439314 |
||
<!--Combo data--> |
<!--Combo data--> |
Revision as of 15:22, 10 September 2011
Combination of | |
---|---|
Lisinopril | ACE inhibitor |
Hydrochlorothiazide | Thiazide diuretic |
Clinical data | |
MedlinePlus | a601070 |
Routes of administration | Oral |
ATC code | |
Legal status | |
Legal status |
|
(verify) |
Lisinopril/hydrochlorothiazide (trade name Prinzide by Merck & Co., Zestoretic by AstraZeneca, and many others) is a combination of the drugs lisinopril, an ACE inhibitor, and hydrochlorothiazide, a diuretic. It is used to control hypertension.
References
- Drugs.com: Prinzide
- Drugs.com: Zestoretic